Common Contracts
8 similar Sales Agreement contracts by Aspen Aerogels Inc, 89bio, Inc., Alx Oncology Holdings Inc, others
SONO GROUP N.V. Ordinary Shares (nominal value €0.06 per share) At Market Issuance Sales AgreementSales Agreement • December 8th, 2022 • Sono Group N.V. • Motor vehicles & passenger car bodies • New York
ASPEN AEROGELS, INC. $150,000,000 OF SHARES OF COMMON STOCK SALES AGREEMENTSales Agreement • March 16th, 2022 • Aspen Aerogels Inc • Wholesale-lumber & other construction materials • New York
Aspen Aerogels, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”) and Piper Sandler & Co. (“Piper” and, together with Cowen, or the “Agents”), as follows:
ASPEN AEROGELS, INC. $150,000,000 OF SHARES OF COMMON STOCK SALES AGREEMENTSales Agreement • March 16th, 2022 • Aspen Aerogels Inc • Wholesale-lumber & other construction materials • New York
Aspen Aerogels, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”) and Piper Sandler & Co. (“Piper” and, together with Cowen, or the “Agents”), as follows:
APPLIED MOLECULAR TRANSPORT INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • January 28th, 2022 • Applied Molecular Transport Inc. • Pharmaceutical preparations • New York
Applied Molecular Transport Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC and JMP Securities LLC (collectively the “Agents,” and each individually an “Agent”), as follows:
ALX ONCOLOGY HOLDINGS INC. Shares of Common Stock (par value $0.001 per share) Sales AgreementSales Agreement • December 17th, 2021 • Alx Oncology Holdings Inc • Pharmaceutical preparations • New York
ALX Oncology Holdings Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. and Credit Suisse Securities (USA) LLC (collectively, the “Agents”, each the “Agent”), as follows:
89bio, Inc. Shares of Common Stock ($0.001 par value per share) SALES AGREEMENTSales Agreement • March 25th, 2021 • 89bio, Inc. • Pharmaceutical preparations • New York
89bio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC and Cantor Fitzgerald & Co. (collectively the “Agents,” and each individually an “Agent”), as follows:
ContraFect Corporation Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • August 14th, 2020 • CONTRAFECT Corp • Pharmaceutical preparations • New York
ContraFect Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. and Maxim Group LLC (each, an “Agent” and together, the “Agents”), as follows:
CRINETICS PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.001 per share) Sales AgreementSales Agreement • August 13th, 2019 • Crinetics Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Crinetics Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC and Cantor Fitzgerald & Co. (collectively the “Agents”, and each individually an “Agent”), as follows:
